Searched for
HEPATITIS DRUG
Zydus Therapeutics' saroglitazar drug granted priority review by US FDAZydus Therapeutics' drug saroglitazar has received priority review from the US FDA. This drug treats primary biliary cholangitis, a liver d...- GSK's chronic hepatitis B drug helps one in five achieve functional cure in key studiesGSK's experimental hepatitis B drug, bepirovirsen, showed promising results in late-stage studies, with nearly one in five patients achievi...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- AbbVie loses patent plea for Hep C drugThe Indian Patent Office has denied a secondary patent for AbbVie's Hepatitis C drug Maviret. This decision ensures continued access to aff...
- World Hepatitis Day: Know about causes, symptoms and risk factorsJuly 28 is reserved to promote awareness of this insidious and deadly virus.
- Dark urine, nausea, abdominal pain? Get checked for hepatitis, it is more dangerous than you thinkHepatitis signs can be asymptomatic, and damage the liver over time leading to cirrhosis.
- Mylan wants to capture chronic Hep B marketThe drug was approved in India in November this year and is the “first” to be approved in eight years for the management of this infection ...
- Johnson & Johnson arm halts R&D on Hepatitis C drugInstead, the company will focus on a cure for chronic hepatitis B, an inflammation of the liver caused by a different virus.
- Hep C drugs will be a Rs 1,000-cr market; Cimivir-L will boost Biocon's virology biz: Kiran Mazumdar-Shaw"The market for Hepatitis C drugs is fairly large. There are high incidences of Hepatitis C in many parts of our country."
- Strides Shasun gets DCGI nod to manufacture Hepatitis C drugLast year, Strides had entered into a licensing agreement with Gilead Sciences to bring Hepatitis C cure to 91 developing countries.
- New medicine for Hepatitis C treatment launchedDuring the conference, two new drugs were launched for treatment of Hepatitis C disease at affordable price.
- Hetero receives drug controller approval for generic DaclatasvirDaclatasvir in combination with Sofosbuvir is indicated for the treatment of Hepatitis C genotype 3 infections, which is highly prevalent i...
- Hetero gets DCGI approval to market Hepatitis C drugHetero is the first company in India to receive the approval for the fixed-dose combination Ledipasvir-Sofosbuvir (90mg/400mg) from DCGI.
- Rs 2,277 drug can treat hepatitis B patientsHepatitis B is transmitted through blood and infected bodily fluids. There is also a risk of infected mothers passing on the Hepatitis B vi...
- Cipla to launch generic Hepatitis C drug 'Hepcvir' in IndiaThe availability of product in other markets is subject to approvals from the regulatory authorities in respective countries, Cipla said.
- Dr Reddy's to launch Hepatitis C drug in IndiaSofosbuvir is a medicine used for chronic Hepatitis C infection and sold globally by Gilead Sciences Inc, under its brand Sovaldi.
- Gilead's hepatitis C drug licensing to benefit more patients: SitharamanA delegation of Gilead Sciences Inc yesterday met Commerce and Industry Minister Nirmala Sitharaman and informed about the signing of non-e...
- Government to set up 10 labs for hepatitis surveillanceGovernment will set up ten regional laboratories through the National Communicable Disease Centre (NCDC) for the surveillance of viral hepa...
- New drug combo cures toughest cases of hepatitis CResults were similar in study participants infected with genotypes 2 or 3, strains which are less common in the US.
- 96,000 die every year due to Hepatitis C in India: ReportThe report said the prevalence of Hepatitis C is estimated to be within 1.8-2.5 per cent, while among drug users it is 50-90 per cent.
Load More
